Essex Bio-Technology Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Essex Bio-Technology Limited with three other
pharmaceutical manufacturers in Asia:
of KOREA (SOUTH)
sales of 140.83 billion Korean Won [US$125.90 million]
of which 85%
was Finished Goods),
Pharma Foods International Co.Ltd
(15.35 billion Japanese Yen [US$139.41 million]
of which 82%
was Functional product(Online business)), and
Shenzhen Weiguang Biological Products Co Ltd
based in CHINA
(904.56 million Chinese Renmimbi [US$141.20 million]
of which 99%
was Blood Products).
Essex Bio-Technology Limited reported sales of HK$978.11 million (US$126.01 million)
December of 2020.
decrease of 23.6%
versus 2019, when the company's sales were HK$1.28 billion.
Contributing to the drop in overall sales was the 26.1% decline
in Ophthalmic Products, from HK$567.54 million to HK$419.23 million.
There were also decreases in sales in
Surgical Products (down 21.5% to HK$558.89 million)